The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. High density lipoprotein decreased 7
METHYLPREDNISOLONE. Histiocytosis haematophagic 7
METHYLPREDNISOLONE. Pneumonia cytomegaloviral 7
METHYLPREDNISOLONE. Posterior reversible encephalopathy syndrome 7
METHYLPREDNISOLONE. Renal impairment 7
METHYLPREDNISOLONE. Septic shock 7
METHYLPREDNISOLONE. Vomiting 7
METHYLPREDNISOLONE MYLAN Febrile bone marrow aplasia 6
METHYLPREDNISOLONE SODIUM SUCCINATE. Hypokalaemia 6
METHYLPREDNISOLONE. Asthenia 6
METHYLPREDNISOLONE. Back pain 6
METHYLPREDNISOLONE. C-reactive protein increased 6
METHYLPREDNISOLONE. Drug ineffective for unapproved indication 6
METHYLPREDNISOLONE. Exposure during pregnancy 6
METHYLPREDNISOLONE. Hypokalaemia 6
METHYLPREDNISOLONE. Neuropathy peripheral 6
METHYLPREDNISOLONE. Off label use 6
METHYLPREDNISOLONE. Porphyria acute 6
METHYLPREDNISOLONE. Renal haemorrhage 6
METHYLPREDNISOLONE. Tachypnoea 6

Total Records: 857     Number of Pages: 43